Drug intelligence / Profile preview

Diaronex

Development stage: Unknown
Lead developer: Innomane
Modality: Small Molecules
Administration: Oral

Overview

Diaronex is a natural health product developed by Innomane Inc. for the treatment of diarrhea. It is formulated from the bark extract of *Holarrhena pubescens* (also known as *Holarrhena antidysenterica*), a medicinal tree native to the Himalayan region with a long history of use in Ayurvedic medicine for gastrointestinal ailments. The product is approved by Health Canada and is available over-the-counter in tablet form. Diaronex functions by creating a protective barrier within the intestinal tract and acting directly against diarrhea-causing microorganisms. It is manufactured in a GMP-certified facility in Toronto and distributed through major Canadian retailers like Rexall.

Brand names: Diaronex
Other names: Holarrhena pubescens bark extractHolarrhena antidysenterica bark extract

Beyond the preview

Go deeper on Diaronex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diaronex.

Explore the full profile